Monthly Archives: December 2009

CBSA Award Winners miRagen and Accera Present at BioBreakfast

CBSA’s final BioBreakfast of the year offered a look inside two of the Award Winners from November’s BioWest Conference: Rising Star Recipient miRagen and Company of the Year Recipient Accera. miRagen CEO Bill Marshall presented first providing an overview of miRagen’s efforts at developing microRNA drugs for the treatment of cardiovascular and muscular conditions. [...]

Array Inks Diabetes Deal with Amgen

Array BioPharma announced it has entered into an agreement with Amgen, Inc that gives Amgen worldwide rights to Array’s small molecule glucokinase activator program. This program includes ARRY-403, a molecule currently in Phase I clinical trials in patients with Type 2 diabetes. Glucokinase activators are designed to increase the activity of glucokinase, an [...]

Holiday Shopping? A Review of the Piano Wizard

Musical ability is not a strong suit of anyone in my family; I believe the last time I picked up an instrument was for a mandatory recorder recital in the third grade (“Senor Don Gato”). So it came as something of a surprise that twenty minutes after walking into the office of Music Wizard I [...]

VanDyne SuperTurbo Named Top Innovator Winner

VanDyne SuperTurbo was selected as a winner of the New England Venture Summit Top Innovation award by youngStartup Ventures. This award recognizes privately held companies leading innovation in technology, life science, and clean tech. As part of this award Kevin Stover, the co-founder and VP of Sales and Marketing, presented at the 2009 [...]

The Week Ahead – Dec 14 – 21

The events taper off this week amidst the holiday season. Monday night offers a Mobile Marketing Colorado event at the Wolf Law Building at CU Boulder. Tuesday sees a New Tech Meetup in Denver, conditional on enough RVSPs. The rest of the week provides two CBSA programs – a BioBreakfast on [...]

miRagen Announces Key microRNA Discovery in ALS

miRagen Therapeutics, Inc announced the publication of data demonstrating the crucial role of microRNA-206 (miR-206) in the progression of ALS (Lou Gehrig’s disease). miRagen has an exclusive license to the intellectual property rights related to this discovery made by a team of researchers led by Eric N Olson at the University of Texas Southwestern [...]

Tim Enwall of Tendril at Entrepreneurs Unplugged

The final edition of Entrepreneurs Unplugged in 2009 saw Tin Enwall, founder, President and COO of Tendril, interviewed by Brad Feld. Enwall described Boulder-based Tendril, which raised a $30 million round of financing in June, as “the residential side of the smart grid.” Before founding Tendril, Enwall’s career had taken him from Apple [...]

MicroPhage Rapid MRSA Test Receives European Approval

MicroPhage announced that it has received a CE Mark to market its rapid, instrument free diagnostics in Europe. The company’s first test uses a blood sample to identify Staphylococcus aureus (“staph”) bacteria and determine the bacterial resistance to methicillin (i.e. whether the bacteria are MRSA). Both these determinations can be made within five [...]

BiOptix Named Top Innovator at New England Venture Summit

BiOptix, which has developed a highly sensitive biosensor, has been selected as a winner of the New England Venture Summit Top Innovator award by youngStartup Ventures. The award recognizes privately held companies that are leading innovators in life sciences and clean tech. This award gives BiOptix CEO Rick Whitcomb the opportunity to present [...]

The Week Ahead: Dec 7 – 14

This week begins with and Entrepreneurs Unplugged featuring Tim Enwall of Boulder-based smart grid company Tendril. The week also offer two programs from CSIA with a business intelligence panel on Wednesday morning and a discussion of software tax issues on Thursday. On the bioscience front, Wednesday sees a program in Colorado Springs [...]